Brief: I-Mab Reports Financial Results For Six Months Ended June 30, 2022

NovaBridge Biosciences

30/08/2022 11:10

Aug 30 (Reuters) - I-Mab  IMAB.O :
    * I-MAB PROVIDES BUSINESS AND CORPORATE UPDATES AND REPORTS
FINANCIAL RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2022
    * I-MAB - LEMZOPARLIMAB IS ON TRACK FOR PHASE 3 STUDY FOR 1L
MDS

Source text for Eikon:  ID:nPn1pV2lWa 
Further company coverage:  IMAB.O 

 ((Reuters.Briefs@thomsonreuters.com;))